China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 465.22M | 494.57M | 523.41M | 534.91M | 549.47M |
| Total Depreciation and Amortization | 466.69M | 459.74M | 451.86M | 448.59M | 446.99M |
| Total Amortization of Deferred Charges | -- | -541.80K | -1.08M | -523.60K | 48.20K |
| Total Other Non-Cash Items | 1.11B | 1.07B | 1.03B | 1.00B | 981.31M |
| Change in Net Operating Assets | 401.14M | 466.63M | 525.10M | 344.46M | 149.28M |
| Cash from Operations | 2.44B | 2.49B | 2.53B | 2.33B | 2.13B |
| Capital Expenditure | -367.83M | -353.73M | -338.79M | -346.67M | -355.87M |
| Sale of Property, Plant, and Equipment | 25.30M | 27.47M | 29.56M | 27.09M | 24.61M |
| Cash Acquisitions | -259.35M | -175.41M | -90.89M | 1.27M | 95.27M |
| Divestitures | -399.40K | 2.56M | 5.51M | 5.51M | 5.51M |
| Other Investing Activities | -633.96M | -521.72M | -408.49M | -232.11M | -53.74M |
| Cash from Investing | -1.24B | -1.02B | -803.10M | -544.92M | -284.21M |
| Total Debt Issued | 79.74B | 79.57B | 79.40B | 82.29B | 85.18B |
| Total Debt Repaid | -86.41B | -87.30B | -88.19B | -87.91B | -87.64B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -207.49M | -164.93M | -121.68M | -121.68M | -121.68M |
| Other Financing Activities | -8.68B | -5.65B | -2.61B | -1.67B | -730.22M |
| Cash from Financing | -2.35B | -2.03B | -1.70B | -1.11B | -498.61M |
| Foreign Exchange rate Adjustments | -4.91M | -2.04M | 839.50K | 1.11M | 1.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.14B | -557.83M | 30.50M | 681.48M | 1.35B |